/

Accolade, Inc.

ACCD US

ACCD USAccolade, Inc.

United States Composite

7.48

USD

+0.15

(+2.05%)

-1.65EPS Dil.

-4.54P/E

575.71MMarket Cap

Accolade, Inc.

ACCD:US

(United States Composite)

Recent

price

7.48

P/E

ratio

-4.54

div

yld

- -

ROIC.AI

Legends:

Stock price

0.93

Beta (1.0 Market)

% total return 05/18

Stock

S&P500

YTD

-32.05

- -

-83.62

- -

2018

2019

2020

2021

2022

2023

TTM

FRC

- -

2.22

2.74

3.83

5.80

4.86

5.09

5.22

- -

-1.77

-1.63

-1.48

-1.72

-1.93

-6.45

-1.65

- -

-1.15

-0.51

-1.08

-0.93

-1.02

-0.60

-0.39

- -

-6.15

-7.78

-6.88

-6.67

-7.37

-13.06

-13.60

- -

-5.30

-6.66

-5.63

6.93

0.49

-0.10

-0.23

- -

133

170

310

363

388

- -

-77.39

-56.93

-36.38

-27.46

-55.20

-45.11

-35.46

- -

-61

-56

-51

-123

-460

-123

- -

-79.77

-59.59

-38.76

-29.73

-39.71

-126.58

-31.59

- -

-18

-10

-21

375

297

247

156

- -

313

310

235

- -

-184

-231

-257

391

856

474

435

- -

Capital Structure

FRC

•

in mil. unless spec.

May'24

Aug'24

Nov'24

ST Debt

LT Borrowings

283

208

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

906

1,026

672

Working Capital

FRC

•

in mil. unless spec.

May'24

Aug'24

Nov'24

Total Current Assets

348

336

272

Cash, Cash Equivalents & STI

303

292

230

Accounts Receivable, Net

Inventories

- -

Total Current Liabilities

113

109

116

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

0.00%

38.13%

17.10%

Net Income, GAAP

-NaN%

-79.61%

-273.98%

Free Cash Flow

-NaN%

-26.81%

33.85%

Total Cash Common Dividend

- -

Total Equity

-NaN%

-42.93%

-44.63%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2022

310

2023

363

2024

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2022

-0.84

-0.97

0.34

-0.51

-1.93

2023

-4.92

-0.66

-0.56

-0.42

-6.45

2024

-0.52

-0.43

-0.28

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2022

- -

2023

- -

2024

- -

Business: Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Company News

Yahoo
18 days ago
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Yahoo Finance
18 days ago
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Tipranks
18 days ago
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
tipranks.com
18 days ago
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
tipranks.com
18 days ago
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Tipranks
18 days ago
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Tipranks
21 days ago
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
tipranks.com
21 days ago
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Benzinga
22 days ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
benzinga
22 days ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tipranks
22 days ago
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
tipranks.com
22 days ago
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
Yahoo Finance
22 days ago
Q4 2024 Accolade Inc Earnings Call
Yahoo
22 days ago
Q4 2024 Accolade Inc Earnings Call
tipranks.com
22 days ago
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
Tipranks
22 days ago
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
tipranks.com
22 days ago
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Tipranks
22 days ago
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Yahoo Finance
22 days ago
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...
Yahoo
22 days ago
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...

Company News

Yahoo
18 days ago
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Yahoo Finance
18 days ago
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Tipranks
18 days ago
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
tipranks.com
18 days ago
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
tipranks.com
18 days ago
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Tipranks
18 days ago
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Tipranks
21 days ago
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
tipranks.com
21 days ago
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Benzinga
22 days ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
benzinga
22 days ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tipranks
22 days ago
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
tipranks.com
22 days ago
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
Yahoo Finance
22 days ago
Q4 2024 Accolade Inc Earnings Call
Yahoo
22 days ago
Q4 2024 Accolade Inc Earnings Call
tipranks.com
22 days ago
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
Tipranks
22 days ago
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
tipranks.com
22 days ago
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Tipranks
22 days ago
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Yahoo Finance
22 days ago
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...
Yahoo
22 days ago
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...

- -

2018

2019

2020

2021

2022

2023

TTM

FRC

- -

2.22

2.74

3.83

5.80

4.86

5.09

5.22

- -

-1.77

-1.63

-1.48

-1.72

-1.93

-6.45

-1.65

- -

-1.15

-0.51

-1.08

-0.93

-1.02

-0.60

-0.39

- -

-6.15

-7.78

-6.88

-6.67

-7.37

-13.06

-13.60

- -

-5.30

-6.66

-5.63

6.93

0.49

-0.10

-0.23

- -

133

170

310

363

388

- -

-77.39

-56.93

-36.38

-27.46

-55.20

-45.11

-35.46

- -

-61

-56

-51

-123

-460

-123

- -

-79.77

-59.59

-38.76

-29.73

-39.71

-126.58

-31.59

- -

-18

-10

-21

375

297

247

156

- -

313

310

235

- -

-184

-231

-257

391

856

474

435

- -